Open access
Sep 2026
Oral sodium butyrate alleviates motor deficits and dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson’s disease rat model
This model indicates the therapeutic potential of oral NaB and provides a translational framework for investigating the mechanisms of NaB therapy in PD and associated neurological disorders and alleviated motor and non-motor deficits in rats with 6-OHDA-induced PD.
Shun-Tai Yang, Yang-Ching Chen, Tzu-Jen Kao et al.
· BMC Neuroscience · 0 citations